Insider Trading activities of Xoma Corp insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Xoma Corp since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Xoma Corp since year 2005. Table 2 shows the detailed insider transactions of Xoma Corp since 2005. The reporting company's ticker symbol is XOMA. The reporting company's CIK number is 791908.
The total value of stock buying since 2005 is $14,191,517.
The total value of stock sales since 2005 is $54,944,674.
The total value of stock option exercises since 2005 is $1,057,740.


 1   2 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Xoma Corp (XOMA).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-11 0 $0 68,518 $1,968,886 68,518 $276,125
2017-05 0 $0 39,540 $246,927 0 $0
2017-03 0 $0 7,703 $41,596 0 $0
2017-02 0 $0 195 $880 0 $0
2017-01 0 $0 125 $643 0 $0
2016-12 0 $0 16,779 $96,478 0 $0
2016-11 0 $0 150 $787 0 $0
2016-10 0 $0 2,500 $1,120 0 $0
2016-05 0 $0 0 $0 11,550 $0
2016-03 0 $0 159,063 $124,863 58,548 $0
2016-02 0 $0 8,000 $8,080 0 $0
2015-12 0 $0 8,000 $10,936 5,600 $0
2015-11 0 $0 8,000 $10,800 0 $0
2015-10 0 $0 8,000 $8,360 0 $0
2015-08 0 $0 0 $0 137,585 $0
2015-07 0 $0 11,048,400 $12,242,859 48,400 $129,136
2015-06 0 $0 10,000 $36,360 10,000 $12,400
2015-05 0 $0 11,788 $39,836 40,566 $12,400
2015-04 0 $0 10,000 $38,610 39,938 $12,400
2015-03 0 $0 42,742 $166,092 178,295 $12,400
2015-02 0 $0 15,000 $52,810 10,000 $12,400
2015-01 0 $0 2,230,400 $8,490,717 10,000 $12,400
2014-12 0 $0 6,164,059 $27,425,908 17,200 $17,264
2014-11 0 $0 36,745 $152,659 171,281 $15,200
2014-10 0 $0 20,000 $81,965 15,000 $27,600
2014-09 0 $0 30,000 $135,715 25,000 $58,000
2014-08 0 $0 119,427 $514,549 166,650 $12,400
2014-07 0 $0 15,000 $63,700 10,000 $12,400
2014-06 0 $0 21,580 $98,006 10,000 $12,400
2014-05 0 $0 21,785 $81,452 40,567 $12,400
2014-04 0 $0 10,000 $40,650 10,000 $12,400
2014-03 0 $0 91,948 $577,818 189,896 $49,219
2014-02 0 $0 16,000 $120,750 16,000 $30,640
2014-01 0 $0 36,000 $292,438 35,694 $63,509
2013-12 0 $0 36,000 $208,360 36,000 $64,440
2013-11 0 $0 204,037 $801,377 182,283 $29,752
2013-10 0 $0 10,746 $49,460 10,746 $14,160
2013-09 0 $0 16,000 $73,045 10,000 $12,400
2013-08 0 $0 91,667 $353,774 166,651 $12,400
2013-07 0 $0 16,000 $76,300 16,000 $28,600
2013-06 0 $0 26,000 $0 23,697 $38,641
2013-05 0 $0 27,797 $19,955 37,002 $38,684
2013-04 0 $0 6,000 $0 0 $0
2013-03 0 $0 6,990 $22,997 19,703 $4,967
2012-12 0 $0 0 $0 833 $1,899
2012-11 0 $0 58,471 $149,567 166,288 $0
2012-10 4,722,666 $14,167,998 0 $0 0 $0
2012-09 0 $0 0 $0 542 $1,900
2012-06 0 $0 0 $0 661 $1,871
2012-03 0 $0 0 $0 1,229 $3,234
2011-11 0 $0 698 $1,116 0 $0
2011-09 0 $0 0 $0 1,022 $1,699
2011-03 5,000 $16,319 0 $0 0 $0
2005-08 5,000 $7,200 0 $0 0 $0
2005-05 0 $0 10,974 $15,473 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Xoma Corp insiders (XOMA)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-11-15 Burns Thomas M. (SVP, Finance & CFO) Sale 8,392 27.24 228,564
2017-11-15 Burns Thomas M. (SVP, Finance & CFO) Option Ex 8,392 4.03 33,819
2017-11-15 Neal James R (CEO) Sale 26,145 27.22 711,588
2017-11-15 Neal James R (CEO) Option Ex 26,145 4.03 105,364
2017-11-14 Burns Thomas M. (SVP, Finance & CFO) Sale 6,847 29.06 198,973
2017-11-14 Burns Thomas M. (SVP, Finance & CFO) Option Ex 6,847 4.03 27,593
2017-11-14 Neal James R (CEO) Sale 8,583 29.01 249,009
2017-11-14 Neal James R (CEO) Option Ex 8,583 4.03 34,589
2017-11-13 Burns Thomas M. (SVP, Finance & CFO) Sale 6,983 31.35 218,917
2017-11-13 Burns Thomas M. (SVP, Finance & CFO) Option Ex 6,983 4.03 28,141
2017-11-13 Neal James R (CEO) Sale 11,568 31.28 361,835
2017-11-13 Neal James R (CEO) Option Ex 11,568 4.03 46,619
2017-05-16 Varian John (Director) Sale 39,540 6.25 246,927
2017-03-21 Burns Thomas M. (VP, Finance & Chief Financial) Sale 2,598 5.40 14,029
2017-03-21 Neal James R (VP Business Development) Sale 5,105 5.40 27,567
2017-02-01 Neal James R (VP Business Development) Sale 195 4.51 880
2017-01-09 Neal James R (VP Business Development) Sale 125 5.15 643
2016-12-21 Varian John (Director) Sale 13,549 5.75 77,906
2016-12-21 Scannon Patrick J Md Phd (Exec. VP & CSO) Sale 3,230 5.75 18,572
2016-11-01 Neal James R (VP Business Development) Sale 150 5.25 787
2016-10-07 Neal James R (VP Business Development) Sale 2,500 .45 1,120
2016-05-28 Walbert Timothy P (Director) Option Ex 2,800 .00 0
2016-05-28 Van Ness W Denman (Director) Option Ex 3,150 .00 0
2016-05-28 Limber Joseph M (Director) Option Ex 2,800 .00 0
2016-05-28 Wyszomierski Jack L (Director) Option Ex 2,800 .00 0
2016-03-22 Burns Thomas M. (VP, Finance & Chief Financial) Sale 19,249 .79 15,110
2016-03-22 Neal James R (VP Business Development) Sale 19,813 .79 15,553
2016-03-22 Varian John (CEO) Sale 81,022 .79 63,602
2016-03-22 Scannon Patrick J Md Phd (Exec. VP & CSO) Sale 14,785 .79 11,606
2016-03-22 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Sale 24,194 .79 18,992
2016-03-18 Varian John (CEO) Option Ex 36,907 .00 0
2016-03-18 Scannon Patrick J Md Phd (Exec. VP & CSO) Option Ex 9,500 .00 0
2016-03-18 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Option Ex 12,141 .00 0
2016-02-01 Scannon Patrick J Md Phd (Exec. VP & CSO) Sale 8,000 1.01 8,080
2015-12-28 Scannon Patrick J Md Phd (Exec. VP & CSO) Sale 8,000 1.37 10,936
2015-12-12 Limber Joseph M (Director) Option Ex 5,600 .00 0
2015-11-23 Scannon Patrick J Md Phd (Exec. VP & CSO) Sale 8,000 1.35 10,800
2015-10-26 Scannon Patrick J Md Phd (Exec. VP & CSO) Sale 8,000 1.04 8,360
2015-08-14 Varian John (CEO) Option Ex 94,573 .00 0
2015-08-14 Scannon Patrick J Md Phd (Exec. VP & CSO) Option Ex 16,264 .00 0
2015-08-14 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Option Ex 26,748 .00 0
2015-07-22 Baker Julian (Other) Sale 11,000,000 1.09 12,023,000
2015-07-15 Varian John (CEO) Sale 10,000 4.49 44,870
2015-07-15 Varian John (CEO) Option Ex 10,000 1.24 12,400
2015-07-15 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Sale 5,000 4.60 22,990
2015-07-15 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Option Ex 5,000 3.04 15,200
2015-07-10 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Sale 29,000 4.55 131,979
2015-07-10 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Option Ex 29,000 3.04 88,160
2015-07-09 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Sale 4,400 4.55 20,020
2015-07-09 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Option Ex 4,400 3.04 13,376
2015-06-15 Varian John (CEO) Sale 10,000 3.64 36,360
2015-06-15 Varian John (CEO) Option Ex 10,000 1.24 12,400
2015-05-28 Walbert Timothy P (Director) Option Ex 5,600 .00 0
2015-05-28 Bowes William K Jr (Director) Option Ex 5,600 .00 0
2015-05-28 Van Ness W Denman (Director) Option Ex 6,300 .00 0
2015-05-28 Limber Joseph M (Director) Option Ex 2,800 .00 0
2015-05-28 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Sale 1,788 3.60 6,436
2015-05-28 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Option Ex 4,666 .00 0
2015-05-28 Wyszomierski Jack L (Director) Option Ex 5,600 .00 0
2015-05-15 Varian John (CEO) Sale 10,000 3.34 33,400
2015-05-15 Varian John (CEO) Option Ex 10,000 1.24 12,400
2015-04-15 Varian John (CEO) Sale 10,000 3.86 38,610
2015-04-15 Varian John (CEO) Option Ex 10,000 1.24 12,400
2015-04-06 Kurland Fred (CFO & VP Finance) Option Ex 29,938 .00 0
2015-03-23 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Sale 32,742 3.94 128,872
2015-03-18 Klein Thomas (Chief Commercial Officer) Option Ex 80,667 .00 0
2015-03-18 Varian John (CEO) Option Ex 36,907 .00 0
2015-03-18 Kurland Fred (CFO & VP Finance) Option Ex 10,875 .00 0
2015-03-18 Scannon Patrick J Md Phd (Exec. VP & CSO) Option Ex 9,500 .00 0
2015-03-18 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Option Ex 30,346 .00 0
2015-03-16 Varian John (CEO) Sale 10,000 3.72 37,220
2015-03-16 Varian John (CEO) Option Ex 10,000 1.24 12,400
2015-02-17 Varian John (CEO) Sale 10,000 3.52 35,190
2015-02-17 Varian John (CEO) Option Ex 10,000 1.24 12,400
2015-02-02 Scannon Patrick J Md Phd (Exec. VP & CSO) Sale 5,000 3.52 17,620
2015-01-15 Varian John (CEO) Sale 10,000 3.46 34,580
2015-01-15 Varian John (CEO) Option Ex 10,000 1.24 12,400
2015-01-06 Baker Julian (Director) Sale 1,000,000 3.86 3,860,000
2015-01-05 Baker Julian (Director) Sale 1,003,300 3.81 3,824,579
2015-01-02 Scannon Patrick J Md Phd (Exec. VP & CSO) Sale 5,000 3.55 17,755
2015-01-02 Baker Julian (Director) Sale 212,100 3.55 753,803
2014-12-30 Baker Julian (Director) Sale 391,900 3.65 1,430,435
2014-12-29 Baker Julian (Director) Sale 221,000 3.68 812,396
2014-12-26 Baker Julian (Director) Sale 131,100 3.71 486,512
2014-12-19 Baker Julian (Director) Sale 752,900 4.21 3,168,956
2014-12-18 Baker Julian (Director) Sale 165,700 4.29 710,687
2014-12-17 Baker Julian (Director) Sale 686,500 4.31 2,958,128
2014-12-16 Baker Julian (Director) Sale 319,200 4.27 1,363,303
2014-12-15 Varian John (CEO) Sale 10,000 4.49 44,930
2014-12-15 Varian John (CEO) Option Ex 10,000 1.24 12,400
2014-12-15 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Sale 1,600 4.63 7,401
2014-12-15 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Option Ex 1,600 3.04 4,864
2014-12-15 Baker Julian (Director) Sale 460,800 4.45 2,050,560
2014-12-12 Limber Joseph M (Director) Option Ex 5,600 .00 0
2014-12-12 Baker Julian (Director) Sale 253,800 4.71 1,196,413
2014-12-09 Baker Julian (Director) Sale 392,353 4.62 1,811,101
2014-12-04 Baker Julian (Director) Sale 1,304,288 4.55 5,929,293
2014-12-03 Baker Julian (Director) Sale 567,918 4.84 2,748,723
2014-12-02 Baker Julian (Director) Sale 500,000 5.36 2,679,500
2014-12-01 Scannon Patrick J Md Phd (Exec. VP & CSO) Sale 5,000 5.51 27,570
2014-11-26 Neal James R (Other) Sale 1,678 5.67 9,514
2014-11-24 Neal James R (VP Business Development) Sale 1,032 5.03 5,193
2014-11-20 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Sale 5,000 4.55 22,750
2014-11-20 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Option Ex 5,000 3.04 15,200
2014-11-13 Neal James R (VP Business Development) Sale 4,387 3.89 17,074
2014-11-13 Varian John (CEO) Sale 2,630 3.89 10,235
2014-11-13 Varian John (CEO) Option Ex 100,664 .00 0
2014-11-13 Walbert Timothy P (Director) Option Ex 4,498 .00 0
2014-11-13 Kurland Fred (CFO & VP Finance) Sale 8,773 3.89 34,144
2014-11-13 Kurland Fred (CFO & VP Finance) Option Ex 22,596 .00 0
2014-11-13 Bowes William K Jr (Director) Option Ex 4,498 .00 0
2014-11-13 Scannon Patrick J Md Phd (Exec. VP & CSO) Sale 8,245 3.89 32,089
2014-11-13 Scannon Patrick J Md Phd (Exec. VP & CSO) Option Ex 22,652 .00 0
2014-11-13 Van Ness W Denman (Director) Option Ex 6,875 .00 0
2014-11-13 Wyszomierski Jack L (Director) Option Ex 4,498 .00 0
2014-11-03 Scannon Patrick J Md Phd (Exec. VP & CSO) Sale 5,000 4.33 21,660
2014-10-28 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Sale 5,000 4.57 22,830
2014-10-28 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Option Ex 5,000 3.04 15,200
2014-10-15 Varian John (CEO) Sale 10,000 3.87 38,690
2014-10-15 Varian John (CEO) Option Ex 10,000 1.24 12,400
2014-10-01 Scannon Patrick J Md Phd (Exec. VP & CSO) Sale 5,000 4.09 20,445
2014-09-15 Varian John (CEO) Sale 10,000 4.56 45,580
2014-09-15 Varian John (CEO) Option Ex 10,000 1.24 12,400
2014-09-15 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Sale 5,000 4.59 22,940
2014-09-15 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Option Ex 5,000 3.04 15,200
2014-09-04 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Sale 10,000 4.56 45,640
2014-09-04 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Option Ex 10,000 3.04 30,400
2014-09-02 Scannon Patrick J Md Phd (Exec. VP & CSO) Sale 5,000 4.31 21,555
2014-08-18 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Sale 16,449 4.36 71,750
2014-08-15 Neal James R (VP Business Development) Sale 6,584 4.61 30,319
2014-08-15 Varian John (CEO) Sale 64,823 4.30 278,933
2014-08-15 Varian John (CEO) Option Ex 10,000 1.24 12,400
2014-08-15 Kurland Fred (CFO & VP Finance) Sale 10,401 4.30 44,776
2014-08-15 Scannon Patrick J Md Phd (Exec. VP & CSO) Sale 5,871 4.30 25,274
2014-08-15 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Sale 10,299 4.30 44,337
2014-08-14 Varian John (CEO) Option Ex 94,574 .00 0
2014-08-14 Kurland Fred (CFO & VP Finance) Option Ex 19,064 .00 0
2014-08-14 Scannon Patrick J Md Phd (Exec. VP & CSO) Option Ex 16,264 .00 0
2014-08-14 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Option Ex 26,748 .00 0
2014-08-01 Scannon Patrick J Md Phd (Exec. VP & CSO) Sale 5,000 3.83 19,160
2014-07-15 Varian John (CEO) Sale 10,000 4.03 40,290
2014-07-15 Varian John (CEO) Option Ex 10,000 1.24 12,400
2014-07-01 Scannon Patrick J Md Phd (Exec. VP & CSO) Sale 5,000 4.68 23,410
2014-06-16 Varian John (CEO) Sale 10,000 4.54 45,410
2014-06-16 Varian John (CEO) Option Ex 10,000 1.24 12,400
2014-06-16 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Sale 11,580 4.54 52,596
2014-05-28 Walbert Timothy P (Director) Option Ex 5,600 .00 0
2014-05-28 Bowes William K Jr (Director) Option Ex 5,600 .00 0
2014-05-28 Van Ness W Denman (Director) Option Ex 6,300 .00 0
2014-05-28 Limber Joseph M (Director) Option Ex 2,800 .00 0
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of XOMA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Xoma Corp (symbol XOMA, CIK number 791908) see the Securities and Exchange Commission (SEC) website.